API Gallery
The Iloperidone market is projected to grow at a CAGR of 5.7% from 2025 to 2035, driven by increasing awareness of mental health disorders, rising demand for antipsychotic medications, and advances in drug delivery technologies.
The Iloprost market is projected to grow at a CAGR of 4.01% from 2025 to 2035, driven by its expanding use in treating pulmonary arterial hypertension (PAH) and other vascular disorders.
The Imatinib Mesylate market is projected to grow at a CAGR between 2.05% and 6.5% from 2025 to 2035, driven by its continued use in treating chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and other cancers.
The Imeglimin Hydrochloride market is projected to grow at a CAGR of approximately 5.0% from 2025 to 2032, driven by its unique mechanism of action and the increasing prevalence of type 2 diabetes globally.
The Imepitoin market is projected to grow at a CAGR of approximately 8.3% from 2025 to 2030, driven by its expanding use in veterinary medicine for treating canine epilepsy and anxiety-related disorders.
The Imidacloprid market is projected to grow at a CAGR between 5.0% and 7.0% from 2025 to 2035, driven by its widespread application in agriculture and pest control.
The Imidacloprid market is projected to grow at a CAGR between 5.0% and 7.0% from 2025 to 2035, driven by its widespread application in agriculture and pest control.
The Irbesartan market is projected to grow at a CAGR of 4.8% from 2025 to 2035, driven by its widespread use in managing hypertension, diabetic nephropathy, and heart failure, along with a rising global burden of cardiovascular diseases.
The Irinotecan Hydrochloride market is projected to grow at a CAGR between 6.0% and 12.9% from 2025 to 2035, driven by its critical role in treating various cancers, particularly colorectal cancer, and advancements in drug formulations.
The Beraprost Sodium market is witnessing a CAGR of 6.5% during the forecast period of 2025-2035. Beraprost sodium is an oral prostacyclin analog used for treating conditions like pulmonary arterial hypertension (PAH) and chronic arterial occlusive disease.
The Labetalol Hydrochloride market is projected to grow at a CAGR of 4.2% from 2025 to 2035, driven by its continued use in the treatment of hypertension, hypertensive emergencies, and its application in managing preeclampsia, along with its strong safety profile and effectiveness in both oral and intravenous formulations.
The Labetalol Hydrochloride market is projected to grow at a CAGR of 5.0% from 2025 to 2035, driven by its continued use in the treatment of hypertension, hypertensive emergencies, and its application in managing preeclampsia, along with its strong safety profile and effectiveness in both oral and intravenous formulations.
Lamotrigine is an anticonvulsant and mood-stabilizing medication widely used in the treatment of epilepsy and bipolar disorder, with the global market expected to grow at a CAGR of 4.5% from 2025 to 2035.
Lanolin is a natural, waxy substance secreted by the sebaceous glands of wool-bearing animals, primarily sheep, and is widely used in the cosmetics, pharmaceutical, and personal care industries. The global lanolin market is projected to grow at a CAGR of approximately 5.2% from 2025 to 2035, fueled by increasing demand for natural and sustainable ingredients in skincare, haircare, and pharmaceutical formulations.
The global levosulpiride market is projected to grow at a CAGR of around 4.7% from 2025 to 2035, driven by its increasing use in functional gastrointestinal disorders such as irritable bowel syndrome (IBS), dyspepsia, and gastroesophageal reflux disease (GERD), as well as its role in psychiatric conditions, particularly anxiety-depression syndromes with somatic complaints.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
